ArticleJournal of cardiovascular and thoracic research2011
Incidence of Cardiovascular Risk Factors in Oskoo (Northwest Iran): An Approach through WHO CVD-risk Management Package for Low-and Medium-Resource Settings on 37,329 Adults ≥30 Years Old.
Article in Journal of cardiovascular and thoracic research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Training nurses in task-shifting strategies for the management and control of hypertension in Ghana: a mixed-methods study.BMC health services research · 2017Trial
- The approach of general practitioners in Lagos to the detection and evaluation of hypertension.Clinical hypertension · 2015Article
- Screening for hypertension among older adults: a primary care "high risk" approach.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2010Article
- Statins for everyone?Heart Asia · 2010Article
- Can non-physician health-care workers assess and manage cardiovascular risk in primary care?Bulletin of the World Health Organization · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of this study was to determine incidence of cardiovascular disease (CVD) risk factors [hypertension (HTN), obesity, Dyslipidemia (DLP), diabetes mellitus (DM) and smoking] in Oskoo.
methodsThis study was planned according to WHO protocol "WHO CVD-risk management package for low and medium-resource settings" and named "East Azerbaijan healthy heart program". The pilot study of this program was done in Oskoo in 2007-2009. In this study, demographic data and CVD risk factors of 37,329 adults aged ≥30 years old living in Oskoo were collected. In addition, blood samples of 17,388 adults ≥40 years old were taken (free of charge) for assessment of serum glucose and lipid profile.
resultsThe study covered 93.52% of Oskoo town population aged≥30 years old. We studied 18637 male (91.50% coverage) and 18692 female (95.52% coverage) participants. The incidence of HTN [SBP≥140 & DBP≥90 mmHg] was 16.25% (M:15.08%, F:17.29%), pre-hypertension [SBP=120-139 & DBP=80-89 mmHg] =37.78% (M:41.38%, F:34.18%), DM [fast blood glucose (FBS)≥126mg/dl] was 7.45% (M:6.35%, F:8.54%), smoking was 9.40% (M:17.00%, F:1.57%), hypercholesterolemia (>200mg/dl) was 47.64% (M:42.46%, F:52.81%) and obesity [body mass index (BMI) ≥27] was 50.47% (M:38.79%, F:62.09%).
conclusionConsidering high incidence of CVD risk factors (except smoking) in Oskoo adults ≥30 years, it is recommended that this pilot study expanded to all of East Azerbaijan. Free of charge taking blood samples from people ≥ 40 years to evaluate lipid profile and glucose levels is worthy to early detecting the prevalent DM or DLP in this target population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.